Spectroscopy Feeds

caprotec's CCMS technology identifies novel co-targets of three anti-cancer drugs

caprotec bioanalytics GmbH announced today the discovery of previously unknown specific drug-protein interactions for several anti-cancer drugs and the identification of potential novel co-targets of the drug molecules through the use of company's CCMS technology.


Read more from original source

Products Updates

  • 1
  • 2
  • 3
  • 4

Microscopy Headlines

  • 1
  • 2
  • 3
  • 4

Spectroscopy Headlines

  • 1
  • 2
  • 3
  • 4